Advertisement

Clinical Research in Cardiology

, Volume 107, Supplement 2, pp 94–99 | Cite as

From early beginnings to elaborate tools: contribution of German electrophysiology to the interventional treatment of cardiac arrhythmias

The German Cardiac Society welcomes ESC in Munich 2018
  • Thomas Fink
  • Michael Schlüter
  • Karl-Heinz Kuck
Review
  • 33 Downloads

Abstract

Catheter ablation evolved from the early days of cardiac electrophysiology (EP), in which invasive electrophysiological studies were mainly a tool to find the correct diagnosis and to evaluate the most effective anti-arrhythmic drug for the patient. Today, catheter ablation is the most effective treatment option for patients suffering from supraventricular and ventricular arrhythmias. The understanding of cardiac arrhythmias and treatment strategies improved because of physicians and scientists from all over the world. The work of German cardiologists led to new achievements in the field of cardiac EP and catheter ablation. In this article, we summarize selective contributions of German EP centres in the field.

Keyword

Cardiac  Arrhythmias 

References

  1. 1.
    Wellens HJJ (1971) Electrical stimulation of the heart in the study and treatment of tachycardias. Leiden, Stenfert KroeseGoogle Scholar
  2. 2.
    Vedel J, Frank R, Fontaine G et al (1978) Bloc auriculoventriculaire intra-hisien definitif induit au cours d’une exploration endoventriculaire droite. Arch Mal Coer 72:107–112Google Scholar
  3. 3.
    Scheinman MM, Morady F, Hess DS, Gonzalez R (1982) Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 248:851–855CrossRefPubMedGoogle Scholar
  4. 4.
    Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, Critelli G (1982) Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 306:194–200CrossRefPubMedGoogle Scholar
  5. 5.
    Borggrefe M, Budde T, Podczeck A, Breithardt G (1987) High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol 10:576–582CrossRefPubMedGoogle Scholar
  6. 6.
    Hindricks G, Haverkamp W, Gulker H, Rissel U, Budde T, Richter KD, Borggrefe M, Breithardt G (1989) Radiofrequency coagulation of ventricular myocardium: improved prediction of lesion size by monitoring catheter tip temperature. Eur Heart J 10:972–984CrossRefPubMedGoogle Scholar
  7. 7.
    Kuck KH, Jackman WM, Pitha J, Kunze KP, Carmen L, Schröder S, Nienaber CA (1988) Percutaneous catheter ablation at the mitral annulus in canines using a bipolar epicardial–endocardial electrode configuration. Pacing Clin Electrophysiol 11(6 Pt 1):760–775CrossRefPubMedGoogle Scholar
  8. 8.
    Jackman WM, Kuck KH, Naccarelli GV, Carmen L, Pitha J (1988) Radiofrequency current directed across the mitral anulus with a bipolar epicardial–endocardial catheter electrode configuration in dogs. Circulation 78(5 Pt 1):1288–1298CrossRefPubMedGoogle Scholar
  9. 9.
    Kuck KH, Schlüter M, Geiger M, Siebels J, Duckeck W (1991) Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet 337:1557–1561CrossRefPubMedGoogle Scholar
  10. 10.
    Jackman WM, Wang XZ, Friday KJ, Roman CA, Moulton KP, Beckman KJ, McClelland JH, Twidale N, Hazlitt HA, Prior MI et al (1991) Catheter ablation of accessory atrioventricular pathways (Wolff–Parkinson–White syndrome) by radiofrequency current. N Engl J Med 324:1605–1611CrossRefPubMedGoogle Scholar
  11. 11.
    Kuck KH, Schlüter M (1991) Single-catheter approach to radiofrequency current ablation of left-sided accessory pathways in patients with Wolff–Parkinson–White syndrome. Circulation 84:2366–2375CrossRefPubMedGoogle Scholar
  12. 12.
    Schlüter M, Kuck KH (1992) Catheter ablation from right atrium of anteroseptal accessory pathways using radiofrequency current. J Am Coll Cardiol 19:663–670CrossRefPubMedGoogle Scholar
  13. 13.
    Deisenhofer I, Zrenner B, Yin YH, Pitschner HF, Kuniss M, Grossmann G, Stiller S, Luik A, Veltmann C, Frank J, Linner J, Estner HL, Pflaumer A, Wu J, von Bary C, Ucer E, Reents T, Tzeis S, Fichtner S, Kathan S, Karch MR, Jilek C, Ammar S, Kolb C, Liu ZC, Haller B, Schmitt C, Hessling G (2010) Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicentre prospective randomized trial. Circulation 122:2239–2245CrossRefPubMedGoogle Scholar
  14. 14.
    Ernst S, Schlüter M, Ouyang F, Khanedani A, Cappato R, Hebe J, Volkmer M, Antz M, Kuck KH (1999) Modification of the substrate for maintenance of idiopathic human atrial fibrillation: efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation 100:2085–2092CrossRefPubMedGoogle Scholar
  15. 15.
    Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666CrossRefPubMedGoogle Scholar
  16. 16.
    Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, Lamprecht K, Barthel P, Luciani E, Schömig A, Schmitt C (2005) Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 111:2875–2880CrossRefPubMedGoogle Scholar
  17. 17.
    Arentz T, Weber R, Bürkle G, Herrera C, Blum T, Stockinger J, Minners J, Neumann FJ, Kalusche D (2007) Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study. Circulation 115:3057–3063CrossRefPubMedGoogle Scholar
  18. 18.
    Ouyang F, Bänsch D, Ernst S, Schaumann A, Hachiya H, Chen M, Chun J, Falk P, Khanedani A, Antz M, Kuck KH (2004) Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 110:2090–2096CrossRefPubMedGoogle Scholar
  19. 19.
    Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT, Schaumann A, Chun J, Falk P, Hennig D, Liu X, Bänsch D, Kuck KH (2005) Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation 111:127–135CrossRefPubMedGoogle Scholar
  20. 20.
    Kuck KH, Hoffmann BA, Ernst S, Wegscheider K, Treszl A, Metzner A, Eckardt L, Lewalter T, Breithardt G, Willems S (2016) Gap-AF–AFNET 1 Investigators. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation-german atrial fibrillation competence network 1 trial. Circ Arrhythm Electrophysiol 9:e003337CrossRefPubMedGoogle Scholar
  21. 21.
    Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, Neven K, Köktürk B, Konstantinidou M, Metzner A, Fuernkranz A, Kuck KH (2010) Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 122:2368–2377CrossRefPubMedGoogle Scholar
  22. 22.
    Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, Mathew S, Yoshiga Y, Wissner E, Kuck KH, Ouyang F (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 60:1921–1929CrossRefPubMedGoogle Scholar
  23. 23.
    Tilz RR, Heeger CH, Wick A, Saguner AM, Metzner A, Rillig A, Wohlmuth P, Reissmann B, Lemeš C, Maurer T, Santoro F, Riedl J, Sohns C, Mathew S, Kuck KH, Ouyang F (2018) Ten-year clinical outcome after circumferential pulmonary vein isolation utilizing the Hamburg approach in patients with symptomatic drug-refractory paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 11:e005250CrossRefPubMedGoogle Scholar
  24. 24.
    Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D, CASTLE-AF Investigators (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378:417–427CrossRefPubMedGoogle Scholar
  25. 25.
    Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, Kurzidim K, Berkowitsch A, Koller M, Heintze J, Scholz U, Wetzel U, Schneider MA, Horstkotte D, Hamm CW, Pitschner HF (2008) Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-centre study. J Am Coll Cardiol 52:273–278CrossRefPubMedGoogle Scholar
  26. 26.
    Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nölker G (2013) Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol 61:1707–1712CrossRefPubMedGoogle Scholar
  27. 27.
    Luik A, Radzewitz A, Kieser M, Walter M, Bramlage P, Hörmann P, Schmidt K, Horn N, Brinkmeier-Theofanopoulou M, Kunzmann K, Riexinger T, Schymik G, Merkel M, Schmitt C (2015) Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, controlled, noninferiority FreezeAF study. Circulation 132:1311–1319CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIRE AND ICE Investigators (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235–2245CrossRefPubMedGoogle Scholar
  29. 29.
    Chun KR, Stich M, Fürnkranz A, Bordignon S, Perrotta L, Dugo D, Bologna F, Schmidt B (2017) Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial. Heart Rhythm 14:495–500CrossRefPubMedGoogle Scholar
  30. 30.
    Wissner E, Heeger CH, Grahn H, Reissmann B, Wohlmuth P, Lemes C, Rausch P, Mathew S, Rillig A, Deiss S, Maurer T, Lin T, Tilz RR, Ouyang F, Kuck KH, Metzner A (2015) One-year clinical success of a ‘no-bonus’ freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation. Europace 17:1236–1240CrossRefPubMedGoogle Scholar
  31. 31.
    Reissmann B, Wissner E, Deiss S, Heeger C, Schlueter M, Wohlmuth P, Lemes C, Mathew S, Maurer T, Sohns C, Saguner A, Santoro F, Hayashi K, Riedl J, Ouyang F, Kuck KH, Metzner A (2017) First insights into cryoballoon-based pulmonary vein isolation taking the individual time-to-isolation into account. Europace 19:1676–1680CrossRefPubMedGoogle Scholar
  32. 32.
    Schmidt B, Neuzil P, Luik A, Osca Asensi J, Schrickel JW, Deneke T, Bordignon S, Petru J, Merkel M, Sediva L, Klostermann A, Perrotta L, Cano O, Chun KRJ (2017) Laser balloon or wide-area circumferential irrigated radiofrequency ablation for persistent atrial fibrillation: a multicentre prospective randomized study. Circ Arrhythm Electrophysiol 10:e005767CrossRefPubMedGoogle Scholar
  33. 33.
    Kuck KH, Reddy VY, Schmidt B, Natale A, Neuzil P, Saoudi N, Kautzner J, Herrera C, Hindricks G, Jaïs P, Nakagawa H, Lambert H, Shah DC (2012) A novel radiofrequency ablation catheter using contact force sensing: TOCCATA study. Heart Rhythm 9:18–23CrossRefPubMedGoogle Scholar
  34. 34.
    Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, Lambert H, Yulzari A, Wissner E, Kuck KH (2013) Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol 6:327–333CrossRefPubMedGoogle Scholar
  35. 35.
    Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, Skoda J, Wichterle D, Wissner E, Yulzari A, Kuck KH (2015) EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 17:1229–1235CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Reddy VY, Shah D, Kautzner J, Schmidt B, Saoudi N, Herrera C, Jaïs P, Hindricks G, Peichl P, Yulzari A, Lambert H, Neuzil P, Natale A, Kuck KH (2012) The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 9:1789–1795CrossRefPubMedGoogle Scholar
  37. 37.
    Ernst S, Ouyang F, Linder C, Hertting K, Stahl F, Chun J, Hachiya H, Bänsch D, Antz M, Kuck KH (2004) Initial experience with remote catheter ablation using a novel magnetic navigation system: magnetic remote catheter ablation. Circulation 109:1472–1475CrossRefPubMedGoogle Scholar
  38. 38.
    Chun JK, Ernst S, Matthews S, Schmidt B, Bansch D, Boczor S, Ujeyl A, Antz M, Ouyang F, Kuck KH (2007) Remote-controlled catheter ablation of accessory pathways: results from the magnetic laboratory. Eur Heart J 28:190–195CrossRefPubMedGoogle Scholar
  39. 39.
    Arya A, Kottkamp H, Piorkowski C, Bollmann A, Gerdes-Li JH, Riahi S, Esato M, Hindricks G (2008) Initial clinical experience with a remote magnetic catheter navigation system for ablation of cavotricuspid isthmus-dependent right atrial flutter. Pacing Clin Electrophysiol 31:597–603CrossRefPubMedGoogle Scholar
  40. 40.
    Rillig A, Schmidt B, Di Biase L, Lin T, Scholz L, Heeger CH, Metzner A, Steven D, Wohlmuth P, Willems S, Trivedi C, Galllinghouse JG, Natale A, Ouyang F, Kuck KH, Tilz RR (2017) Manual versus robotic catheter ablation for the treatment of atrial fibrillation: the Man and Machine trial. JACC Clin Electrophysiol 3:875–883CrossRefPubMedGoogle Scholar
  41. 41.
    Sommer P, Grothoff M, Eitel C, Gaspar T, Piorkowski C, Gutberlet M, Hindricks G (2013) Feasibility of real-time magnetic resonance imaging-guided electrophysiology studies in humans. Europace 15:101–108CrossRefPubMedGoogle Scholar
  42. 42.
    Piorkowski C, Grothoff M, Gaspar T, Eitel C, Sommer P, Huo Y, John S, Gutberlet M, Hindricks G (2013) Cavotricuspid isthmus ablation guided by real-time magnetic resonance imaging. Circ Arrhythm Electrophysiol 6:e7–e10CrossRefPubMedGoogle Scholar
  43. 43.
    Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS, VTACH study Group (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375:31–40CrossRefPubMedGoogle Scholar
  44. 44.
    Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, Zarse M, Hohnloser SH, Kautzner J, Willems S; SMS Investigators (2017) Impact of substrate modification by catheter ablation on implantable cardioverter–defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol 10:e004422CrossRefPubMedGoogle Scholar
  45. 45.
    Kottkamp H, Hindricks G, Chen X, Brunn J, Willems S, Haverkamp W, Block M, Breithardt G, Borggrefe M (1995) Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy. Circulation 92:1159–1168CrossRefPubMedGoogle Scholar
  46. 46.
    Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C, Hindricks G, Arya A (2014) Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation 129:728–736CrossRefPubMedGoogle Scholar
  47. 47.
    Ouyang F, Cappato R, Ernst S, Goya M, Volkmer M, Hebe J, Antz M, Vogtmann T, Schaumann A, Fotuhi P, Hoffmann-Riem M, Kuck KH (2002) Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the purkinje network. Circulation 105:462–469CrossRefPubMedGoogle Scholar
  48. 48.
    Ouyang F, Fotuhi P, Ho SY, Hebe J, Volkmer M, Goya M, Burns M, Antz M, Ernst S, Cappato R, Kuck KH (2002) Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol 39:500–508CrossRefPubMedGoogle Scholar
  49. 49.
    Ouyang F, Mathew S, Wu S, Kamioka M, Metzner A, Xue Y, Ju W, Yang B, Zhan X, Rillig A, Lin T, Rausch P, Deiß S, Lemes C, Tönnis T, Wissner E, Tilz RR, Kuck KH, Chen M (2014) Ventricular arrhythmias arising from the left ventricular outflow tract below the aortic sinus cusps: mapping and catheter ablation via transseptal approach and electrocardiographic characteristics. Circ Arrhythm Electrophysiol 7:445–455CrossRefPubMedGoogle Scholar
  50. 50.
    Siebels J, Cappato R, Rüppel R, Schneider MA, Kuck KH (1993) Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. Am J Cardiol 72:109F–113FCrossRefPubMedGoogle Scholar
  51. 51.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–1583CrossRefGoogle Scholar
  52. 52.
    Kuck KH, Cappato R, Siebels J, Rüppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102:748–754CrossRefPubMedGoogle Scholar
  53. 53.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21:2071–2078CrossRefPubMedGoogle Scholar
  54. 54.
    Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the cardiomyopathy trial (CAT). Circulation 105:1453–1458CrossRefPubMedGoogle Scholar
  55. 55.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med 352:225–237CrossRefPubMedGoogle Scholar
  56. 56.
    Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158CrossRefPubMedGoogle Scholar
  57. 57.
    Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, DANISH Investigators (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221–1230CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Thomas Fink
    • 1
  • Michael Schlüter
    • 2
  • Karl-Heinz Kuck
    • 1
  1. 1.Department of CardiologyAsklepios Klinik St. GeorgHamburgGermany
  2. 2.Asklepios ProresearchHamburgGermany

Personalised recommendations